GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amneal Pharmaceuticals Inc (FRA:2DT) » Definitions » Accounts Payable

Amneal Pharmaceuticals (FRA:2DT) Accounts Payable : €212 Mil (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Amneal Pharmaceuticals Accounts Payable?

Amneal Pharmaceuticals's Accounts Payable for the quarter that ended in Sep. 2024 was €212 Mil.

Amneal Pharmaceuticals's quarterly Accounts Payable increased from Mar. 2024 (€161 Mil) to Jun. 2024 (€185 Mil) and increased from Jun. 2024 (€185 Mil) to Sep. 2024 (€212 Mil).

Amneal Pharmaceuticals's annual Accounts Payable increased from Dec. 2021 (€116 Mil) to Dec. 2022 (€157 Mil) but then declined from Dec. 2022 (€157 Mil) to Dec. 2023 (€132 Mil).

Amneal Pharmaceuticals Accounts Payable Historical Data

The historical data trend for Amneal Pharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amneal Pharmaceuticals Accounts Payable Chart

Amneal Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable
Get a 7-Day Free Trial 92.72 125.88 116.01 156.69 131.66

Amneal Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 166.22 131.66 161.30 185.41 211.74

Amneal Pharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Amneal Pharmaceuticals Accounts Payable Related Terms

Thank you for viewing the detailed overview of Amneal Pharmaceuticals's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Amneal Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amneal Pharmaceuticals Inc (FRA:2DT) » Definitions » Accounts Payable
Comparable Companies
PETQ HROW PAHC COLL EOLS SIGA PROC AVDL BKUH ORGO ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
AMRX:USA
Address
400 Crossing Boulevard, 3rd Floor, Bridgewater, NJ, USA, 08807
Website
https://www.amneal.com
Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Amneal Pharmaceuticals Headlines

No Headlines